Mini midbrains provide next generation platforms to investigate human brain biology, diseases and therapeutics
Scientists in Singapore have made a big leap on research on the ‘mini-brain’. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson’s Disease (PD) and ageing-related brain diseases.
These mini midbrain versions are three-dimensional miniature tissues that are grown in the laboratory and they have certain properties of specific parts of the human brains. This is the first time that the black pigment neuromelanin has been detected in an organoid model. The study also revealed functionally active dopaminergic neurons.
The human midbrain, which is the information superhighway, controls auditory, eye movements, vision and body movements. It contains special dopaminergic neurons that produce dopamine – which carries out significant roles in executive functions, motor control, motivation, reinforcement, and reward. High levels of dopamine elevate motor activity and impulsive behaviour, whereas low levels of dopamine lead to slowed reactions and disorders like PD, which is characterised by stiffness and difficulties in initiating movements.
Also causing PD is the dramatic reduction in neuromelanin production, leading to the degenerative condition of patients, which includes tremors and impaired motor skills. This creation is a key breakthrough for studies in PD, which affects an estimated seven to 10 million people worldwide. Furthermore, there are people who are affected by other causes of parkinsonism. Researchers now have access to the material that is affected in the disease itself, and different types of studies can be conducted in the laboratory instead of through simulations or on animals. Using stem cells, scientists have grown pieces of tissue, known as brain organoids, measuring about 2 to 3 mm long. These organoids contain the necessary hallmarks of the human midbrain, which are dopaminergic neurons and neuromelanin.
Jointly led by Prof Ng Huck Hui from A*STAR’s Genome Institute of Singapore (GIS) and Assistant Prof Shawn Je from Duke-NUS Medical School, this collaborative research between GIS, Duke-NUS, and the National Neuroscience Institute (NNI) is funded by the National Medical Research Council’s Translational Clinical Research (TCR) Programme In Parkinson’s disease (PD) and A*STAR. Other collaborators are from the Lieber Institute for Brain Development, the Johns Hopkins University School of Medicine, and the Nanyang Technological University.
Assistant Prof Shawn Je from Duke-NUS Medical School’s Neuroscience & Behavioural Disorders Programme said, “It is remarkable that our midbrain organoids mimic human midbrain development. The cells divide, cluster together in layers, and become electrically and chemically active in three-dimensional environment like our brain. Now we can really test how these mini brains react to existing or newly developed drugs before treating patients, which will be a game changer for drug development.”
Prof Tan Eng King, Research Director and Senior Consultant, Department of Neurology at NNI and Lead PI of the TCR Programme in PD, remarked, “The human brain is arguably the most complex organ and chronic brain diseases pose considerable challenges to doctors and patients. This achievement by our Singapore team represents an initial but momentous scientific landmark as we continue to strive for better therapies for our patients.”
GIS Executive Director Prof Ng Huck Hui said, “Considering one of the biggest challenges we face in PD research is the lack of accessibility to the human brains, we have achieved a significant step forward. The midbrain organoids display great potential in replacing animals’ brains which are currently used in research; we can now use these midbrains in culture instead to advance our understanding and future studies for the disease, and perhaps even other related diseases.”
Learn more: Singapore scientists grow mini human brains
The Latest on: Midbrain organoids
[google_news title=”” keyword=”midbrain organoids” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Midbrain organoids
- Neural organoidson February 29, 2024 at 4:00 pm
Stem cells are known to be capable to differentiate into specialized cells, even under in-vitro settings, and to form 3D organ-like structures in a dish, often referred to as organoids.
- Mini model of human embryonic brain and spinal cord grown in labon February 28, 2024 at 11:52 am
For the first time, scientists have grown a tiny, three-dimensional model of the earliest developmental stages of the human central nervous system in the lab.The new model is a type of organoid — a ...
- Using Patient-Derived Organoids to Predict Treatment Response in Pancreatic Canceron February 26, 2024 at 4:00 pm
Interest in patient-derived organoids for the treatment of pancreatic cancer is growing because organoids better recapitulate the complexity and population diversity of patients as compared to ...
- Researchers identify diverse neuron types associated with vulnerability to Parkinson's diseaseon January 12, 2024 at 10:04 am
The researchers validated this human finding of RIT2-enriched neurons in both midbrain organoids and the substantia nigra of mice. The results demonstrate distinct transcriptomic signatures of the ...
- Organoids: The New Frontieron November 22, 2023 at 1:23 pm
Researchers use stem cells to grow organoids—3D miniature organs—in cell culture. They use these to gain insight into organ development and disease, and to screen new drug therapies. As new ...
- Innovative applications of brain organoids in neurological studieson November 13, 2023 at 3:55 am
Organoids derived from various brain regions, such as the forebrain, midbrain, and hippocampus, are cultured and employed as in vitro models for investigating neurobiological and ...
- Organoids: How Close Are We to The Clinic?on February 3, 2023 at 9:33 am
Organoids play an increasingly critical role in clinical drug development and screening, as well as for regenerative medicine applications. As researchers integrate organoids into a wider range of ...
- Personalized Neuroscience: Are Human-Derived Brain Organoids The Answer?on December 20, 2022 at 1:44 pm
Opinions expressed by Forbes Contributors are their own. I write about neuroscience and its intersection with technology. Imagine a futuristic society capable of curing devastating neurological ...
- Nothing to cry about: The development of tear duct organoidson June 3, 2022 at 8:05 am
Advancements in cell culture methods have allowed for the development of organoids—stem cell-derived mini-organs that mimic the tissue organization of our body. Now, researchers in Japan have ...
- Intestinal Organoids and Their Role in Tissue Engineeringon November 3, 2021 at 4:21 pm
Intestinal stem cells can be expanded and functionally differentiated to form “mini-organs” or organoids that resemble the architecture and function of the native intestinal epithelium. Organoids are ...
via Bing News